$QCLS

Q/C Technologies, Inc.

Nasdaq · Healthcare · In Vitro & In Vivo Diagnostic Substances · New York, NY

QCLS chart

What traders are saying about $QCLS

Latest posts

Q/C Technologies, Inc. news

Q/C Technologies, Inc. key financials

USD2025202420232022
Revenue––––
Net income-$11.6M-$23.4M-$4.0M-$15.2M
Diluted EPS$-8.66$-1080.87$-5.33$-11.74
Total assets (year end)$41.2M$21.4M$17.9M$17.5M
Cash and equivalents (year end)$986,996$173,154$2.7M$749,090

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Q/C Technologies, Inc.

Ticker
QCLS (Nasdaq)
Industry
In Vitro & In Vivo Diagnostic Substances
Headquarters
New York, NY
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
1321834
Former names
Q/C TECHNOLOGIES, INC., TNF Pharmaceuticals, Inc., MyMD Pharmaceuticals, Inc.

Frequently asked questions

What exchange is Q/C Technologies, Inc. listed on?

Q/C Technologies, Inc. trades on the Nasdaq under the ticker symbol QCLS.

What industry is Q/C Technologies, Inc. in?

Q/C Technologies, Inc. is classified by the SEC under "In Vitro & In Vivo Diagnostic Substances", part of the Healthcare sector on StockTweeting.

Where is Q/C Technologies, Inc. headquartered?

Q/C Technologies, Inc.'s business address on file with the SEC is in New York, NY.

When does Q/C Technologies, Inc.'s fiscal year end?

Q/C Technologies, Inc.'s fiscal year ends on December 31.

How much revenue did Q/C Technologies, Inc. report?

Q/C Technologies, Inc. reported $1.6M in revenue for calendar year 2019, according to its SEC filings.